These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2526270)

  • 1. Effect of (+/-)-methyl 3-ethyl-2,3,3a,4-tetrahydro-1H-indolo-[3,2,1-de] [1,5] naphthyridine-6-carboxylate hydrochloride (OM-853), a new vincamine analogue, on the metabolism and function of cerebral serotonergic neurons.
    Koda H; Hashimoto T; Katsura M; Kuriyama K
    Jpn J Pharmacol; 1989 Mar; 49(3):413-21. PubMed ID: 2526270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices.
    Muramatsu M; Tamaki-Ohashi J; Usuki C; Araki H; Chaki S; Aihara H
    Eur J Pharmacol; 1988 Aug; 153(1):89-95. PubMed ID: 2975224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
    Koda H; Hashimoto T; Kuriyama K
    Eur J Pharmacol; 1989 Mar; 162(3):501-8. PubMed ID: 2744083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vinconate, an indolonaphthyridine derivative, on metabolism and function of cerebral cholinergic neurons in rat.
    Iino T; Katsura M; Kuriyama K
    Neurochem Int; 1993 Nov; 23(5):399-405. PubMed ID: 8251925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G; Barzizza A; Folghera S; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated electroconvulsive shocks on serotonergic neurons.
    Blier P; Bouchard C
    Eur J Pharmacol; 1992 Feb; 211(3):365-73. PubMed ID: 1535597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
    Wieland S; Kreider MS; McGonigle P; Lucki I
    Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum.
    Bonanno G; Maura G; Raiteri M
    Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
    Hjorth S; Sharp T; Liu Y
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
    Deliganis AV; Pierce PA; Peroutka SJ
    Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum.
    Raiteri M; Maura G; Bonanno G; Pittaluga A
    J Pharmacol Exp Ther; 1986 May; 237(2):644-8. PubMed ID: 2871177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.